CLMT

CLMT

USD

Calumet Inc. Common Stock

$10.480+0.260 (2.544%)

Reaalajas hind

Põhimaterjalid
Erikemikaalid
Ameerika Ühendriigid

Hinnagraafik

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$10.220

Kõrge

$10.500

Madal

$9.811

Maht

0.16M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

903.5M

Tööstusharu

Erikemikaalid

Riik

United States

Kauplemisstatistika

Keskmine maht

1.39M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $7.68Praegune $10.480Kõrge $25.29

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 20. apr 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

[CLMT: Calumet Inc. Common Stock]: Navigating Mixed Signals - What's the Play?

Stock Symbol: CLMT Generate Date: 2025-04-20 22:06:14

Alright, let's take a look at Calumet Inc. (CLMT). It's a company in specialty chemicals and renewable fuels – think niche products and green energy, which can be interesting areas right now. But what's actually happening with the stock? Let's break it down without the Wall Street mumbo jumbo.

Recent News Buzz: A Bit of Both

The news lately is a mixed bag, honestly. On one hand, Wells Fargo, a big bank, still thinks Calumet is worth holding onto ("Overweight" rating). That's generally a good sign. However, they did lower their target price – from $28 down to $23. Think of it like this: they still like the stock, but they're not quite as excited as they were before. Maybe they see some bumps in the road ahead, or just think it'll take a bit longer to reach that higher price.

Then, there's news about Calumet selling off some parts of their Royal Purple business. Selling assets can sound scary, but in this case, it seems like a strategic move. They're focusing on their core areas, which can be a smart way to streamline and become more efficient. Plus, selling assets usually means they get a cash injection, which can be helpful for a company.

So, the news isn't screaming "buy" or "sell." It's more like a yellow light – proceed with caution, but there might be something interesting here.

Price Check: Downhill Lately, But Maybe Finding a Floor?

Looking at the stock price over the last month or so, it's been mostly downhill. Started back in late January around $18, and now it's hovering around $9-ish. That's a pretty significant drop. You can see it clearly in the data – a lot of red days, especially in March. It wasn't a smooth slide either; there were some bounces and dips, making it a bit of a rollercoaster for anyone holding it.

However, if you squint at the very recent price action in April, it might be trying to stabilize around this $9-$10 range. It's definitely lower than it was, but the really sharp drops seem to have slowed down.

Now, what does the AI say? Funny enough, the AI prediction is also mixed, just like the news. It's predicting a tiny dip today, then a small bump up tomorrow, and then another little dip the day after. Basically, not expecting any huge moves in the immediate short term.

Outlook & Strategy Ideas: Patience Might Be Key

Putting it all together, what's the vibe? It feels like Calumet is in a bit of a transition. The asset sale suggests they're reshaping the company. The price drop shows investors haven't been thrilled recently, but maybe the selling pressure is easing. And the AI isn't pointing to any dramatic shifts right now.

So, what's the potential play? It's probably not a screaming "buy right now" situation. But it's also not necessarily time to panic and sell if you already own it. It feels more like a "hold and watch" scenario.

Potential Entry Consideration (If you're thinking of buying): If you're interested in Calumet for the longer term, maybe keep an eye on that $9-$10 area. If it holds as support – meaning the price doesn't fall much below it – that could be an interesting point to consider dipping your toes in. Why? Because it's near the recent lows, and the recommendation data even mentions a "strong buying opportunity" around $9.76 (support level). But again, cautious language here – could be, might be.

Potential Exit/Stop-Loss Consideration (For current holders or potential buyers): On the downside, if the price breaks below, say, $8.78 (which is mentioned as a stop-loss level in the recommendation data), that might be a signal to reconsider your position and cut losses. Nobody wants to watch a stock keep falling. On the upside, if it does bounce, maybe look at the $10.70 area as a potential first profit target – again, based on the recommendation data. These levels are just potential guideposts for managing risk.

Company Context: Renewables & Specialty Chemicals Matter

Quick reminder: Calumet is in the specialty chemicals and renewable fuels business. The renewable fuels part is definitely something to watch. With the push towards green energy, that sector could have growth potential down the line. Their Royal Purple brand is also known for performance, so they have some solid brands in their portfolio. They're not a giant tech company, but they're in sectors that could become more important.

In short: Calumet is a bit of a puzzle right now. Mixed news, a falling price that might be stabilizing, and AI predictions that aren't giving a clear signal. Patience and careful observation seem like the best approach. Watch those price levels, keep an eye on news about the company's restructuring and renewable fuel efforts, and see how things develop.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. I'm just breaking down the data as I see it. Investing in the stock market involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Seotud uudised

PR Newswire

Calumet, Inc. to Release First Quarter 2025 Earnings on May 9, 2025

Calumet, Inc. (NASDAQ: CLMT) (the "Company," "Calumet," "we," "our" or "us"), announced today that it plans to report results for the First Quarter...

Vaata rohkem
Calumet, Inc. to Release First Quarter 2025 Earnings on May 9, 2025
Analyst Upgrades

Wells Fargo Maintains Overweight on Calumet, Lowers Price Target to $23

Wells Fargo analyst Roger Read maintains Calumet with a Overweight and lowers the price target from $28 to $23.

Vaata rohkem
Wells Fargo Maintains Overweight on Calumet, Lowers Price Target to $23

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 28. apr 2025, 02:55

LangevNeutraalneTõusev

66.4% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Väärtus
Kauplemisjuhend

Sisenemispunkt

$10.35

Võta kasum

$11.46

Peata kahjum

$9.44

Põhitegurid

PDI 21.9 on MDI 11.8 kohal ADX-iga 12.4, mis viitab tõusutrendile
Praegune hind on tugitasemele ($10.38) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 6.5x keskmisest (14,823), mis viitab äärmiselt tugevale ostusurvele
MACD 0.0262 on signaalijoone 0.0216 kohal, mis viitab tõusvale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.